{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:07:08Z","timestamp":1791180428258,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.josat.2025.209693","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:58:42Z","timestamp":1744372722000},"page":"209693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention"],"prefix":"10.1016","volume":"173","author":[{"given":"Antoine","family":"Khati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Copenhaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Wickersham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209693_bb0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/1471-2458-10-676","article-title":"Comparing sexual risks and patterns of alcohol and drug use between injection drug users (IDUs) and non-IDUs who report sexual partnerships with IDUs in St. Petersburg, Russia","volume":"10","author":"Abdala","year":"2010","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.josat.2025.209693_bb0010","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1007\/s10461-019-02767-3","article-title":"Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: A qualitative study","volume":"24","author":"Allen","year":"2020","journal-title":"AIDS and Behavior"},{"issue":"1","key":"10.1016\/j.josat.2025.209693_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","article-title":"Opioid use fueling HIV transmission in an urban setting: An outbreak of HIV infection among people who inject drugs\u2014Massachusetts, 2015\u20132018","volume":"110","author":"Alpren","year":"2020","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.josat.2025.209693_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0749-3797(18)30622-6","article-title":"Screening for depression in well older adults: Evaluation of a short form of the CES-D","volume":"10","author":"Andresen","year":"1994","journal-title":"American Journal of Preventive Medicine"},{"issue":"7","key":"10.1016\/j.josat.2025.209693_bb0025","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1016\/S2468-2667(21)00112-2","article-title":"HIV pre-exposure prophylaxis: Scaling up for impact now and in the future","volume":"6","author":"Bavinton","year":"2021","journal-title":"The Lancet Public Health"},{"issue":"1","key":"10.1016\/j.josat.2025.209693_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12954-018-0263-5","article-title":"Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs","volume":"15","author":"Biello","year":"2018","journal-title":"Harm Reduction Journal"},{"issue":"4","key":"10.1016\/j.josat.2025.209693_bb0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11904-021-00556-z","article-title":"The past, present, and future of PrEP implementation among people who use drugs","volume":"18","author":"Biello","year":"2021","journal-title":"Current HIV\/AIDS Reports"},{"issue":"4","key":"10.1016\/j.josat.2025.209693_bb0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/1073191113481998","article-title":"Psychometric properties of the CES-D-10 in a psychiatric sample","volume":"20","author":"Bj\u00f6rgvinsson","year":"2013","journal-title":"Assessment"},{"issue":"1","key":"10.1016\/j.josat.2025.209693_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.olq.0000148294.83012.d0","article-title":"Sexual risk among injection drug users recruited from syringe exchange programs in California","volume":"32","author":"Bogart","year":"2005","journal-title":"Sexually Transmitted Diseases"},{"key":"10.1016\/j.josat.2025.209693_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105779","article-title":"Sexual risk behaviors and STDs among persons who inject drugs: A national study","volume":"126","author":"Brookmeyer","year":"2019","journal-title":"Preventive Medicine"},{"issue":"4","key":"10.1016\/j.josat.2025.209693_bb0055","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10508-020-01791-y","article-title":"Factors associated with being PrEP-na\u00efve among a U.S. National Cohort of former-PrEP and PrEP-na\u00efve participants meeting objective criteria for PrEP care","volume":"50","author":"Carneiro","year":"2021","journal-title":"Archives of Sexual Behavior"},{"key":"10.1016\/j.josat.2025.209693_bb0060","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.josat.2025.209693_bb0065","author":"Centers for Disease Control and Prevention"},{"issue":"2","key":"10.1016\/j.josat.2025.209693_bb0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00002030-199102000-00008","article-title":"The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users","volume":"5","author":"Darke","year":"1991","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.josat.2025.209693_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1265063","article-title":"The use of oral HIV pre-exposure prophylaxis among people who inject drugs: Barriers, and recommendations [opinion]","volume":"11","author":"Dzinamarira","year":"2023","journal-title":"Frontiers in Public Health"},{"issue":"5","key":"10.1016\/j.josat.2025.209693_bb0080","article-title":"Oral pre-exposure prophylaxis (PrEP) to prevent HIV: A systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations","volume":"12","author":"E","year":"2022","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.josat.2025.209693_bb0085","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s10461-014-0867-z","article-title":"Acceptability of HIV pre-exposure prophylaxis (PREP) among people who inject drugs (PWID) in a Canadian setting","volume":"19","author":"Escudero","year":"2015","journal-title":"AIDS and Behavior"},{"issue":"9","key":"10.1016\/j.josat.2025.209693_bb0090","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1007\/s10461-023-04012-4","article-title":"Does the association between stimulant use and high risk sexual behavior vary by injection drug use, sexual minority status, or HIV infection status? A Meta-analysis","volume":"27","author":"Feelemyer","year":"2023","journal-title":"AIDS Behav"},{"key":"10.1016\/j.josat.2025.209693_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.113809","article-title":"\u201cPrEP just isn\u2019t my priority\u201d: Adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in Philadelphia, PA USA","volume":"275","author":"Felsher","year":"2021","journal-title":"Social Science & Medicine"},{"issue":"6","key":"10.1016\/j.josat.2025.209693_bb0100","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s10508-020-01684-0","article-title":"An exploration of pre-exposure prophylaxis (PrEP) initiation among women who inject drugs","volume":"49","author":"Felsher","year":"2020","journal-title":"Archives of Sexual Behavior"},{"key":"10.1016\/j.josat.2025.209693_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.healthplace.2014.04.008","article-title":"Accessibility and utilization patterns of a mobile medical clinic among vulnerable populations","volume":"28","author":"Gibson","year":"2014","journal-title":"Health & Place"},{"key":"10.1016\/j.josat.2025.209693_bb0110","author":"Gilead Sciences"},{"issue":"2","key":"10.1016\/j.josat.2025.209693_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2471\/BLT.12.109553","article-title":"Mitigating the risk of HIV infection with opioid substitution treatment","volume":"91","author":"Gowing","year":"2013","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.josat.2025.209693_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.annepidem.2020.10.003","article-title":"Evidence for HIV transmission across key populations: A longitudinal analysis of HIV and AIDS rates among Black people who inject drugs and Black heterosexuals in 84 large U.S. metropolitan areas, 2008-2016","volume":"55","author":"Ibragimov","year":"2021","journal-title":"Annals of Epidemiology"},{"issue":"1","key":"10.1016\/j.josat.2025.209693_bb0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12954-021-00518-z","article-title":"Factors that influence enrollment in syringe services programs in rural areas: A qualitative study among program clients in Appalachian Kentucky","volume":"18","author":"Ibragimov","year":"2021","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2025.209693_bb0130","first-page":"1","article-title":"Integrated addendum to ICH E6 (R1): Guideline for good clinical practice E6 (R2)","volume":"2","author":"International Council for Harmonisation","year":"2015","journal-title":"Current Step"},{"issue":"1","key":"10.1016\/j.josat.2025.209693_bb0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12954-025-01171-6","article-title":"Prevalence and predictors of condom use among people who inject drugs in Georgia","volume":"22","author":"Kajaia","year":"2025","journal-title":"Harm Reduction Journal"},{"issue":"7","key":"10.1016\/j.josat.2025.209693_bb0140","doi-asserted-by":"crossref","first-page":"ofz310","DOI":"10.1093\/ofid\/ofz310","article-title":"Same-day HIV pre-exposure prophylaxis (PrEP) initiation during drop-in sexually transmitted diseases clinic appointments is a highly acceptable, feasible, and safe model that engages individuals at risk for HIV into PrEP care","volume":"6","author":"Kamis","year":"2019","journal-title":"Open Forum Infectious Diseases"},{"issue":"10","key":"10.1016\/j.josat.2025.209693_bb0145","doi-asserted-by":"crossref","DOI":"10.2196\/42585","article-title":"Nurse practitioner-led integrated rapid access to HIV prevention for people who inject drugs (iRaPID): Protocol for a pilot randomized controlled trial","volume":"11","author":"Khati","year":"2022","journal-title":"JMIR Res Protoc"},{"issue":"Suppl. 5","key":"10.1016\/j.josat.2025.209693_bb0150","doi-asserted-by":"crossref","first-page":"S301","DOI":"10.1093\/infdis\/jiaa130","article-title":"Ending the HIV epidemic among persons who inject drugs: A cost-effectiveness analysis in six US cities","volume":"222","author":"Krebs","year":"2020","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.josat.2025.209693_bb0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2016.02.044","article-title":"Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC","volume":"164","author":"Kuo","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"23","key":"10.1016\/j.josat.2025.209693_bb0160","article-title":"Modeling the evolution of the US opioid crisis for national policy development","volume":"119","author":"Lim","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.josat.2025.209693_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.josat.2025.209693_bb0170","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/QAD.0000000000000613","article-title":"The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs","volume":"29","author":"Martin","year":"2015","journal-title":"AIDS (London, England)"},{"issue":"1","key":"10.1016\/j.josat.2025.209693_bb0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12954-024-00983-2","article-title":"Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: A pilot study","volume":"21","author":"McKellar","year":"2024","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.josat.2025.209693_bb0180","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s10461-018-2238-7","article-title":"Factors associated with sexual risks and risk of STIs, HIV and other blood-borne viruses among women using heroin and other drugs: A systematic literature review","volume":"23","author":"Medina-Perucha","year":"2019","journal-title":"AIDS and Behavior"},{"issue":"4","key":"10.1016\/j.josat.2025.209693_bb0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.sc.3102127","article-title":"Measurement properties of the CESD scale among individuals with spinal cord injury","volume":"46","author":"Miller","year":"2008","journal-title":"Spinal Cord"},{"issue":"5","key":"10.1016\/j.josat.2025.209693_bb0190","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s10461-020-02988-x","article-title":"The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: A systematic review","volume":"25","author":"Mistler","year":"2021","journal-title":"AIDS and Behavior"},{"issue":"8","key":"10.1016\/j.josat.2025.209693_bb0195","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.2105\/AJPH.2014.301897","article-title":"Latent tuberculosis infection screening in foreign-born populations: A successful mobile clinic outreach model","volume":"104","author":"Morano","year":"2014","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2025.209693_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108540","article-title":"Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder","volume":"133","author":"Morgan","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209693_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108477","article-title":"Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment","volume":"219","author":"Ni","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2025.209693_bb0210","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale:A Self-Report Depression Scale for Research in the General Population","volume":"1","author":"Radloff","year":"1977","journal-title":"Applied Psychological Measurement"},{"key":"10.1016\/j.josat.2025.209693_bb0215","first-page":"1","article-title":"An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users","volume":"45","author":"Roth","year":"2017","journal-title":"Sexually Transmitted Diseases"},{"issue":"2","key":"10.1016\/j.josat.2025.209693_bb0220","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/S2352-3018(20)30256-3","article-title":"Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention","volume":"8","author":"Rowan","year":"2021","journal-title":"The Lancet HIV"},{"key":"10.1016\/j.josat.2025.209693_bb0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fpubh.2018.00195","article-title":"Exploring the use of pre-exposure prophylaxis (PrEP) for HIV prevention among high-risk people who use drugs in treatment","volume":"6","author":"Shrestha","year":"2018","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.josat.2025.209693_bb0230","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.12.023","article-title":"Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment","volume":"173","author":"Shrestha","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209693_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.103033","article-title":"Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study","volume":"88","author":"Smith","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"10.1016\/j.josat.2025.209693_bb0240","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2105\/AJPH.2022.306793","article-title":"Associated costs are a barrier to HIV preexposure prophylaxis access in the United States","volume":"112","author":"Srikanth","year":"2022","journal-title":"American Journal of Public Health"},{"issue":"7","key":"10.1016\/j.josat.2025.209693_bb0245","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.21346","article-title":"Prevalence of HIV Preexposure prophylaxis prescribing among persons with commercial insurance and likely injection drug use","volume":"5","author":"Streed","year":"2022","journal-title":"JAMA Network Open"},{"issue":"5","key":"10.1016\/j.josat.2025.209693_bb0250","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1097\/OLQ.0000000000001577","article-title":"Limited risk compensation among women who inject drugs: Results from the project sexual health equity Preexposure prophylaxis demonstration study in Philadelphia","volume":"49","author":"Tran","year":"2022","journal-title":"Sexually Transmitted Diseases"},{"key":"10.1016\/j.josat.2025.209693_bb0255","author":"US Public Health Service"},{"key":"10.1016\/j.josat.2025.209693_bb0260","author":"US Public Health Service"},{"issue":"1","key":"10.1016\/j.josat.2025.209693_bb0265","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1186\/s12913-020-05568-w","article-title":"The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: A scoping review","volume":"20","author":"Vanhamel","year":"2020","journal-title":"BMC Health Services Research"},{"issue":"1","key":"10.1016\/j.josat.2025.209693_bb0270","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: Development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Molecular Psychiatry"},{"issue":"14","key":"10.1016\/j.josat.2025.209693_bb0275","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1080\/10826084.2020.1823419","article-title":"HIV pre-exposure prophylaxis prevention awareness, willingness, and perceived barriers among people who inject drugs in Los Angeles and San Francisco, CA, 2016-2018","volume":"55","author":"Walters","year":"2020","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2025.209693_bb0280","author":"World Health Organization"},{"issue":"20","key":"10.1016\/j.josat.2025.209693_bb0285","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"9\u201310","key":"10.1016\/j.josat.2025.209693_bb0290","first-page":"244","article-title":"The public health approach to the worsening opioid crisis in the United States calls for harm reduction strategies to mitigate the harm from opioid addiction and overdose deaths","volume":"187","author":"Yeo","year":"2021","journal-title":"Military Medicine"},{"issue":"11","key":"10.1016\/j.josat.2025.209693_bb0295","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1007\/s10461-021-03227-7","article-title":"Use of pre-exposure prophylaxis among people who inject drugs: Exploratory findings of the interaction between race, homelessness, and trust","volume":"25","author":"Zhou","year":"2021","journal-title":"AIDS and Behavior"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:06:32Z","timestamp":1774530392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925000724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":59,"alternative-id":["S2949875925000724"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209693","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209693"}}